Mitochondria and heart failure: New insights into an energetic problem

Minerva Cardioangiologica

Volumn 58, Issue 2, 2010, Pages 213-229

  Chen, L ^a   Knowlton, A A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Heart failure; Mitochondria, heart; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; ESTROGEN; REACTIVE OXYGEN METABOLITE;

AGING; APOPTOSIS; CALCIUM TRANSPORT; ENERGY METABOLISM; ENERGY TRANSFER; HEART FAILURE; HEART MITOCHONDRION; HUMAN; NONHUMAN; PROTEIN SECRETION; REVIEW;

AGING; ANIMALS; APOPTOSIS; CALCIUM; ESTROGENS; HEART FAILURE; HUMANS; MITOCHONDRIA;

EID: 77954741221     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (193)

1. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41
2. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9.
3. Neubauer S. The failing heart - An engine out of fuel. N Engl J Med 2007;356:1140-51.
4. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res 2009;81:412-9.
5. Ingwall JS, Weiss RG. Is the failing heart energy starved?: On using chemical energy to support cardiac function. Circ Res 2004;95:135-45.
6. Gustafsson AB, Gotdieb RA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007;292:C45-C51.
7. Rosenberg P. Mitochondrial dysfunction and heart disease. Mitochondrion 2004;4:621-8.
8. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet 2004;364:1786-88.
9. Hoshijima M, Knöll, Pashmforoush M, Chien KR. Reversal of calcium cycling defects in advanced heart failure: toward molecular therapy. J Am Coll Cardiol 2O06;48:A15-A23.
10. Beer M, Seyfarth T, Sandstede J, Landschütz W, Lipke C, Köstler H et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spec- troscopy. J Am Coll Cardiol 2002;40:1267-74.
11. Sanbe A, Tanonaka K, Kobayashi R, Takeo S. Effects of long-term therapy with ACE inhibitors, Captopril, enalapril and trandolpril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol 1995;27:2209-22.
12. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF et al Progressive loss of myocardial atp due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 1999;100:2113-8. (Pubitemid 29532064)
13. Sabbah HN, Sharov V, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1992;24:1333-47.
14. McCutcheon LJ, Cory CR, Nowack L, Shen H, Mirsalami M, Lahucky R et al Respiratory chain defect of myocardial mitochondria in idiopathic dilated cardiomyopathy of Doberman pinscher dogs. Can J Physiol Pharmacol 1992;70:1529-33.
15. Rosca MG, Okere IA, Sharma N, Stanley WC, Recchia FA, Hoppel CL. Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure. J Mol Cell Cardiol 2009;46:927-35.
16. Gamier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003;551:491-501.
17. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN. Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 2000;32:2361-7. (Pubitemid 32039785)
18. Sharov VG, Goussev A, Lesch M, Goldstein S, Sabbah HN. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1998;30:1757-62.
19. Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res 2008;80:30-9.
20. Sparagna GC, Lesnefsky EJ. Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 2009;53.
21. Molyneux SL, Florkowski CM, Richards AM, Lever M, Young JM, George PM. Coenzyme Q10; an adjunctive therapy for congestive heart failure? N Z Med J 2009;122:74-9.
22. Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M etal. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 2008;52:1435-41.
23. Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A 1985;82:901-4. (Pubitemid 15142785)
24. Grover GJ, Atwal KS, Sleph PG, Wang FL, Monshizadegan H, Monticello T et al. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol 2004;287:H1747-H55.
25. Dorner A, Schulze K, Rauch U, Schultheiss HP. Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem 1997;174:261-9. (Pubitemid 127739060)
26. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997;16:226-34.
27. Ning XH, Zhang J, Liu J, Ye Y, Chen SH, From AH et al Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction. J Am Coll Cardiol 2000;36:282-7.
28. Ventura-Clapier R, Garnier A, Veksler V Transcriptional control of mitochondrial biogenesis: the central role of PGC-1{alpha} Cardiovasc Res 2008;79:208-17.
29. Arany Z, Novikov M, Chin S, Ma Y, Rosenzweig A, Spiegelman BM. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci USA 2006;103:10086-91.
30. Laskowski KR, Russell RR III. Uncoupling proteins in heart failure. Curr Heart Fail Rep 2008;5:75-9.
31. Faadiel Essop M, Opie LH. Metabolic therapy for heart failure. Eur Heart J 2004;25:1765-8.
32. Nabben M, Hoeks J. Mitochondrial uncoupling protein 3 and its role in cardiac- and skeletal muscle metabolism. Physiol Behav 2008;94:259-69.
33. Brennan JP, Southworth R, Medina RA, Davidson SM, Duchen MR, Shattock MJ. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res 2006;72:313-21.
34. Gao H, Chen L, Yang HT. Activation of {alpha}1B-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes. Cardiovasc Res 2007;75:584-95.
35. Tani M, Honma Y, Hasegawa H, Tamaki K. Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res 2001;49:56-68.
36. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998;10:248-53.
37. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart faillure. Br Heart J 1991;65:245-8.
38. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-20.
39. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000;86:152-7.
40. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Utsumi H, Nakamura R et al. Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc Res 2001;49:103-9.
41. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal 2006;8:1737-44.
42. Sawyer DB, Colucci WS. Mitochondrial oxidative stress in heart failure: "Oxygen Wastage" Revisited. Circ Res 2000;86:119-20.
43. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999;85:357-63.
44. Nojiri H, Shimizu T, Funakoshi M, Yamaguchi O, Zhou H, Kawakami S et al Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 2006;281:33789-801.
45. Siwik DA, Tzortzis JD, Pimentai DR, Chang DL, Pagano PJ, Singh K et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 1999;85:147-53. (Pubitemid 29343313)
46. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
47. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-23.
48. Zell R, Geck P, Werdan K, Boekstegers P. TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function. Mol Cell Biochem 1997;177:61-7. (Pubitemid 27522359)
49. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 2004;279:47961-7.
50. Sack MN. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 2006;72:210-9.
51. Nakayama H. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 2007;117:2431-44.
52. Houser SR, Piacentino III V, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 2000;32:1595-607.
53. Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006;34:232-7.
54. Territo PR, Mootha VK, French SA, Balaban RS. Ca2+ activation of heart mitochondrial oxidative phosphorylation: role of the F0/F1-ATPase. Am J Physiol Cell Physiol 2000;278:C423-C35.
55. Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondrial calcium transport: mechanisms and functions. Cell Calcium 2000;28:285-96.
56. Dhalla NS, Tomlinson CW, Yates JC, Lee SL, Varley KG, Borowski IF et al. Role of mitochondrial calcium transport in failing heart. Recent Adv Stud Cardiac Struct Metab 1975;5:177-87.
57. Liu T, O'Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 2008;103:279-88.
58. Griffiths EJ, Ocampo CJ, Savage JS, Rutter GA, Hansford RG, Stern MD et al Mitochondrial calcium transporting pathways during hypoxia and reoxygenation in single rat cardiomyocytes. Cardiovasc Res 1998;39:423-33.
59. Murata M, Akao M, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 2001;89:891-8.
60. Namekata I, Shimada H, Kawanishi T, Tanaka H, Shigenobu K. Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload. Eur J Pharmacol 2006;543:108-15.
61. Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J. Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res 2006;71:715-24.
62. Garcia-Rivas GJ, Carvajal K, Correa F, Zazueta C. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo. Br J Pharmacol 2006;149:829-37.
63. Michels G, Khan IF, Endres-Becker J, Rottlaender D, Herzig S, Ruhparwar A et al. Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels. Circulation 2009;119:2435-43.
64. Crompton M, Barksby E, Johnson N, Capano M. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 2002;84:143-52.
65. Hajnóczky G, Csordás G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S et al. Mitochondrial calcium signalling and cell death: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 1911;40:553-60.
66. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005;434:658-62.
67. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005;434:652-8.
68. Griffiths EJ, Ocampo CJ, Savage JS, Stern MD, Silverman HS. Protective effects of low and high doses of cydosporin A against reoxygenation injury in isolated rat cardiomyocytes are associated with differential effects on mitochondrial calcium levels. Cell Calcium 2000;27:87-95.
69. Sharov VG, Todor AV, Imai M, Sabbah HN. Inhibition of mitochondrial permeability transition pores by cydosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes. Heart Fail Rev 2005;10:305-10.
70. Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Ore Physiol 2006;290:H2024-H34.
71. Knowlton AA, Kapadia S, Torre-Amione G, Durand JB, Bies R, Young J et al Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol 1998;30:811-8.
72. Gupta S, Knowlton AA. HSP60, Bax, apoptosis and the heart. J Cel Mol Med 2005;9:51-8.
73. Wu C, Yan L, Depre C, Dhar SK, Shen YT, Sadoshima J et al Cytochrome C oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction. Am J Physiol Cell Physiol 2009;
74. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD et al Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999;96:8144-9.
75. Satoh M, Matter CM, Ogita H, Takeshita K, Wang CY, Dorn GW 2nd et al. Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive HEART FAILURE by Estrogen. Circulation 2007;115:3197-204.
76. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-9. (Pubitemid 32851517)
77. Joza N, Oudit GY, Brown D, Bénit P, Kassiri Z, Vahsen N et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 2005;25:10261-72.
78. Siu PM, Bae S, Bodyak N, Rigor DL, Kang PM. Response of caspase-independent apoptotic factors to high salt diet-induced HEART FAILURE. J Mol Cell Cardiol 2007;42:678-86.
79. Haider N, Arbustini E, Gupta S, Liu H, Narula N, Hajjar R et al Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med 2009;6:250-61.
80. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57. (Pubitemid 26256586)
81. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549-56. (Pubitemid 129518401)
82. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13.
83. Chang J, Wei L, Otani T, Youker KA, Entman ML, Schwartz RJ. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation 2003;108:407-13.
84. Adams JM, Cory S. The Bd-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
85. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000;103:645-54.
86. Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc Res 2008;77:334-43.
87. Capano M, Crompton M. Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 2006;395:57-64.
88. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP et al Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 1998;97:194-203.
89. Huang J, Nakamura K, Ito Y, Uzuka T, Morikawa M, Hirai S et al Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation 2005;112:76-83.
90. Chen M, He H, Zhan S, Krajewski S, Reed JC, Gottlieb RA. Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 2001;276:30724-8.
91. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al. Response to myocardial ischemia//reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2006;14:146-57.
92. Kubli DA, Ycaza JE, Gustafsson sB. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 2007;405:407-15.
93. Regula KM, Ens K, Kirshenbaum LA. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes. Circ Res 2002;91:226-31. (Pubitemid 34875677)
94. Sah VP, Minamisawa S, Tarn SP, Wu TH, Dorn GW 2nd, Ross J Jr et al. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 1999;103:1627-34.
95. Del Re DP, Miyamoto S, Brown JH. RhoA/rho kinase up-regulate bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 2007;282:8069-78.
96. Lin L, Kim SC, Wang Y, Gupta S, Davis B, Simon SI et al HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 2007;293:H2238-H47.
97. Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002;106:2727-33. (Pubitemid 35364929)
98. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. Hsp10 and Hsp60 modulate Bd-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac musde cells. J Mol Cell Cardiol 2003;35:1135-43.
99. Wang Y, Knowlton AA, Christensen TG, Shih T, Borkan SC. Prior heat stress inhibits apoptosis in adenosine triphosphate-depleted renal tubular cells. Kidney Int 1999;55:2224-35.
100. Lin KM, Lin B, Lian IY, Mestril R, Scheffler IE, Dillmann WH. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001;103:1787-92. (Pubitemid 32291417)
101. Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 2002;105:2899-904.
102. Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBOJ 1999;18:2040-8.
103. Wang Y, Chen L, Hagiwara N, Knowlton AA. Regulation of heat shock protein 60 and 72 expression in the failing heart. J Mol Cell Cardiol 2010;48:360-6.
104. Kim SC, Stice JP, Chen L, Jung JS, Gupta S, Wang Y et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res 2009;105:1186-95.
105. Meeusen SL, Nunnari J. How mitochondria fuse. Curr Opin Cell Biol 2005;17:389-94.
106. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125:1241-52.
107. Nunnari J, Marshall WF, Straight A, Murray A, Sedat JW, Walter P. Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell 1997;8:1233-42. (Pubitemid 27310471)
108. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Dip1, and Opal in apoptosis. Mol Biol Cell 2004;15:5001-11.
109. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F etal. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-25.
110. Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 1998;143:351-8.
111. Yoon Y, Krueger EW, Oswald BJ, McNiven MA. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLPl. Mol Cell Biol 2003;23:5409-20.
112. Stojanovski D, Koutsopoulos OS, Okamoto K, Ryan MT. Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology. J Cell Sd 2004;117:1201-10.
113. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T et al Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane perme- abilization. Developmental Cell 2008;14:193-204.
114. Bleazard W, McCaffery JM, King EJ, Bale S, Mozdy A, Tieu Q et al. The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast. Nat Cell Biol 1999;1:298-304. (Pubitemid 129495781)
115. Ishihara N, Jofuku A, Eura Y, Mihara K. Regulation of mitochondrial morphology by membrane potential, and DRP1-dependent division and FZO1-dependent fusion reaction in mammalian cells. Biochem Biophys Res Commun 2003;301:891-8.
116. Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related Protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001;12:2245-56. (Pubitemid 33051954)
117. Suzuki M, Jeong SY, Karbowski M, Youle RJ, Tjandra N. The solution structure of human mitochondria fission protein Fis1 reveals a novel TPR-like helix bundle. J Mol Biol 2003;334:445-58.
118. Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 2003;116:2763-74.
119. Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 2006;25:2966-77.
120. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P et al. Loss of OPA1 perturbâtes the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003;278:7743-46.
121. Olichon A, Elachouri G, Baricault L, Delettre C, Belenguer P, Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restrirted function in apoptosis. Cell Death Differ 2007;14:682-92.
122. Satoh M, Hamamoto T, Seo N, Kagawa Y, Endo H. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem Biophys Res Commun 2003;300:482-93.
123. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003;160:189-200. (Pubitemid 36254953)
124. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-5.
125. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-10.
126. Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-51.
127. Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of charcot-marie-tooth disease from mitofusin 2 mutations. J Neurosd 2007;27:422-30.
128. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A et al. Spatial and temporal association of Bax with mitochondrial fission sites, Dip1, and Mfn2 during apoptosis. J Cell Biol 2002;159:931-8.
129. Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, Youle RJ. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 2004; 164: 493-9.
130. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006;443:658-62. (Pubitemid 44564703)
131. Brooks C, Wei Q, Feng L, Dong G, Tao Y, Mei L et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci U S A 2007;104:11649-54.
132. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase deavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 2003;160:1115-27.
133. James DI, Parone PA, Mattenberger Y, Martinou JC. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 2003;278:36373-9.
134. Chen L, Gong Q Stice JP, Knowlton AA. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc Res 2009;84:91-9.
135. Medeiros DM, Jennings D. Role of copper in mitochondrial biogenesis via interaction with ATP synthase and cytochrome c oxidase. J Bioenerg Biomembr 2002;34:389-95.
136. Tandler B, Hoppel CL. Possible division of cardiac mitochondria. Anat Rec 1972;173:309-23.
137. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005;120:159-62.
138. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009;104:150-8.
139. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M, Kirshenbaum LA et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 2007;14:146-57. (Pubitemid 44911902)
140. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T et al Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007;100:914-22.
141. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006;281:29776-87.
142. Yan L, Vatner DE, Kim SJ, Vatner SF. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005;102:13807-812.
143. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001;88:529-35.
144. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 1998;153:1501-10.
145. Santorelli FM, Mak SC, El-Schahawi M, Casali C, Shanske S, Baram TZ et al Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am J Hum Genet 1996;58:933-9. (Pubitemid 26115164)
146. Terman A, Brunk UT. The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart, Lung Circulation 2005;14:107-14.
147. Forman DE, Rich MW. Heart failure in the elderly. Congest Heart Fail 2003;9:311-21.
148. Coleman R, Silbermann M, Gershon D, Reznick AZ. Giant mitochondria in the myocardium of aging and endurance-trained mice. Gerontology 1987;33:34-9. (Pubitemid 17076589)
149. Sachs HG, Colgan JA, Lazarus ML. Ultrastructure of the aging myocardium: a morphometric approach. Am J Anat 1977;150:63-71.
150. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Mitochondrial recycling and aging of cardiac myocytes: the role of autophagocytosis. Exp Gerontol 2003;38:863-76.
151. Hoppel CL, Tandler B, Fujioka H, Riva A. Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol 2009;41:1949-56.
152. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci 2004;1019:70-7.
153. Navratil M, Terman A, Arriaga EA. Giant mitochondria do not fuse and exchange their contents with normal mitochondria. Experimental Cell Research 2008;314:164-72.
154. Lee S, Jeong SY, Lim WC, Kim S, Park YY, Sun X et al. Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J Biol Chem 2007;282:22977-83.
155. Khrapko K, Bodyak N, Thilly WG, van Orsouw NJ, Zhang X, Coller HA et al. Cell-by-cell scanning of whole mitochondrial genomes in aged human heart reveals a significant fraction of myocytes with donally expanded deletions. Nucleic Acids Res 1999;27:2434-41.
156. Wenzel P, Schuhmacher S, Kienhöfer J, Müller J, Hortmann M, Oelze M et al Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc Res 2008;80:280-9.
157. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005;04-2622fje.
158. Muscari C, Caldarera CM, Guarnieri C. Age-dependent production of mitochondrial hydrogen peroxide, lipid peroxides and fluorescent pigments in the rat heart. Basic Res Cardiol 1990;85:172-8. (Pubitemid 20150093)
159. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005;308:1909-11.
160. Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009;119:2789-97.
161. Pelzer T, Shamim A, Wolfges S, Schumann M, Neyses L. Modulation of cardiac hypertrophy by estrogens. Adv Exp Med Biol 1997;432:83-9.
162. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2005;1746:1-17.
163. Chen JQ, Eshete M, Alworth WL, Yager JD. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J Cell Biochem 2004;93:358-73.
164. Chen JQ, Yager JD. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis. Ann N Y Acad Sci 2004;1028:258-72.
165. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T et al. Mitochondrial localization of estrogen receptor beta. Proc Nad Acad Sd U S A 2004;101:4130-5.
166. Adams KF Jr, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG et al. Gender differences in survival in advanced HEART FAILURE. Insights from the FIRST study. Circulation 1999;99:1816-21.
167. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Pina LL, Granger CB et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 2007;115:3111-20.
168. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA et al. Myocyte death in the failing human heart is gender dependent. Circ Res 1999;85:856-66. (Pubitemid 29504161)
169. 169- Mohan SB, Parker M, Wehbi M, Douglass P. Idiopathic dilated cardiomyopathy: a common but mystifying cause of HEART FAILURE. Cleve Clin J Med 2002;69:481-7. (Pubitemid 34678942)
170. Fernandez-Sola J, Nicolas-Arfelis JM. Gender differences in alcoholic cardiomyopathy. J Gend Specif Med 2002;5:41-7. (Pubitemid 34467388)
171. Zhai P, Eurell TE, Cooke PS, Lubahn DB, Gross DR. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol 2000;278:H1640-H7.
172. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR. Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 2006;290:H2204-H9.
173. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 2005;38:289-97.
174. Wang M, Crisostomo PR, Markel T, Wang Y, Lillemoe KD, Meldrum DR. Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery 2008;144:233-8.
175. Stice JP, Lee JS, Pechenino AS, Knowlton AA. Estrogen, aging and the cardiovascular system. Future Cardiol 2009;5:93-103.
176. Psarra AMG, Solakidi S, Sekeris CE. The mitochondrion as a primary site of action of steroid and thyroid hormones: Presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells. Mol Cell Endocrinol 2006;246:21-33. (Pubitemid 43238393)
177. Psarra AM, Sekeris CE. Steroid and thyroid hormone receptors in mitochondria. IUBMB Life 2008;60:210-23.
178. Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009;1793:1540-70.
179. O'Lone R, Knorr K, Jaffe IZ, Schaffer ME, Martini PG, Karas RH et al. Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol 2007;21:1281-96.
180. Virbasius JV, Scarpulla RC. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Nad Acad Sci USA 1994;91:1309-13.
181. Kang D, Kim SH, Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007;7:39-44.
182. Hsieh YC, Yang S, Choudhry MA, Yu HP, Rue LW 3rd, Bland KI etal PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after traumahemorrhage. Am J Physiol Heart Circ Physiol 2005;289:H2665-H72.
183. Mattingly KA, Ivanova MM, Riggs KA, Wickramasinghe NS, Barch MJ, Klinge CM. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 2008;22:609-22.
184. Stirone C, Duckies SP, Krause DN, Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Molecular Pharmacology 2005;68:959-65.
185. Ikeuchi M, Matsusaka H, Kang D, Matsushima S, Ide T, Kubota T et al. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial defidendes and cardiac failure after myocardial infarction. Circulation 2005;112:683-90.
186. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Nad Acad Sci U S A 2001;98:4038-43.
187. Kressler D, Schreiber SN, Knutti D, Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 2002;277:13918-925.
188. Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM, McDonnell DP. Modulation of estrogen receptor-alpha transcriptional adivity by the coactivator PGC-1. J Biol Chem 2000;275:16302-8.
189. Hsieh YC, Yu HP, Suzuki T, Choudhry MA, Schwacha MG, Bland KI et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following traumahemorrhage. J Mol Cell Cardiol 2006;41:511-21. (Pubitemid 44344281)
190. Sihag S, Cresa S, Li AY, Sucharov CC, Lehman JJ. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 2009;46:201-12.
191. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009;29:9090-103.
192. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 2003;278:17190-7.
193. Wang X, Su B, Fujioka H, Zhu X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 2008;173:470-82.